menu
    • menu

    Company profile for ChemWerth Inc

    ChemWerth-PSE
    News
    ChemWerth Appoints New GSM to Expand India Generic API Reach

    12 Jan 2026

    // PRESS RELEASE

    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Chemwerth

    Contact Supplier

    Website

    CPhI China

    Booth #E1B03

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/chemwerth-inc/a-full-service-api-company

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Related CompaniesRelated Companies

    About

    ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships for product development, compliance, and secure logistics. ChemWerth accesses over 500 APIs and 30 manufacturing facilities across the US, Europe, India, and China, acts as a regulatory agent for 25+ FDA-approved facilities, sells 100+ products, and operates in 38 countries. In 2020, it filed its 500th DMF with the FDA . Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ChemWerth IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1764 Litchfield Turnpike Woodbridge, CT 06525
    Telephone
    Telephone
    +1 2033877794
    Client Email
    Email
    jon.moore@chemwerth.com
    Client Website
    Website
    https://chemwerth.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/chemwerth-inc/
    youtube
    YouTube
    http://www.youtube.com/@ChemWerth
    Twitter
    Twitter
    Contact Info
    Others

    ChemWerth Pharmaceutical Technology Co., Ltd. (China)

    20 Floor, BIO Building,
    No. 1326 YanAn Road (West),
    Shanghai 200052 China

    021-52585258

    Email ID:
    chinaoffice@chemwerth.com

     

    ChemWerth (India)

    B-604, 6th Floor
    The Platina
    Near Radisson Hotel
    Gachibowli
    Hyderabad 500 032

    Email ID:
    sales@chemwerth.com

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI China

    Booth #E1B03

    envelop Contact Supplier

    CPhI China

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    mic“Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 1639

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    read-more

    ReelPharmaA Full-Service API CompanyA Full-Service API Company

    A Full-Service API Company
    A Full-Service API Company

    reelA Full-Service API Company

    This PharmaReel showcases ChemWerth, a full-service generic API company with over 40 years of experience, offering cGMP-quality APIs through 30+ manufacturing partners across the US, EU, India, and China, backed by 550+ global filings, and expertise in new product development, compliance, and logistics.

    Impressions: 2526

    read-more

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2026

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-99334.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-27403.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Nitrosamine & Genotoxic Impurity 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-76959.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    The ChemWerth Advantage 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-50147.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    ChemWerth Celebrates 40 Years in Business

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-23090.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    A New Look at ANDA Approvals

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-1642651741.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    ChemWerth Appoints New GSM to Expand India Generic API Reach
    ChemWerth Appoints New GSM to Expand India Generic API Reach

    12 Jan 2026

    // PRESS RELEASE

    https://chemwerth.com/chemwerth-appoints-new-general-sales-manager-to-increase-its-generic-api-footprint-in-india/

    PRESS RELEASE
    12 Jan 2026
    Share Share
    ChemWerth Names New CEO
    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    https://chemwerth.com/announcement-of-leadership-changes/

    PRESS RELEASE
    18 Jun 2024
    Share Share
    Supply Chain Security If Your API Supply Is Important
    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    https://chemwerth.com/supply-chain-security-if-your-api-supply-is-important-you-should-take-5-minutes-to-read-this/

    PRESS RELEASE
    05 Sep 2023
    Share Share
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023

    24 May 2023

    // PRESS RELEASE

    https://chemwerth.com/pharmatech-outlook-names-chemwerth-as-a-top-drug-discovery-and-development-company-of-2023-2/

    PRESS RELEASE
    24 May 2023
    Share Share
    Peter Werth Recieves Honorary Degree From Housatonic College
    Peter Werth Recieves Honorary Degree From Housatonic College

    23 May 2023

    // PRESS RELEASE

    https://chemwerth.com/peter-werth-recieves-honorary-degree-from-housatonic-community-college/

    PRESS RELEASE
    23 May 2023
    Share Share
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion

    21 May 2023

    // PRESS RELEASE

    https://chemwerth.com/woodbridge-pharma-company-chemwerth-eyes-overseas-expansion/

    PRESS RELEASE
    21 May 2023
    Share Share

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Services

    Discover the service capabilities from this company

    Sales, Marketing, Registration

    Discover their expertise for : Sales, Marketing, Registration

    Inspections and registrations

    Check the inspections & registration from this company
    Chemwerth

    ABOUT THIS PAGE

    Contact ChemWerth Inc and get a quotation

    ChemWerth Inc is a supplier offers 36 products (APIs, Excipients or Intermediates).

    Find a price of Foscarnet Sodium bulk with DMF, CEP offered by ChemWerth Inc

    Find a price of Ropivacaine Hydrochloride bulk with DMF, CEP offered by ChemWerth Inc

    Find a price of Argatroban Monohydrate bulk with DMF offered by ChemWerth Inc

    Find a price of Arsenic Trioxide bulk with DMF offered by ChemWerth Inc

    Find a price of Azacitidine bulk with DMF offered by ChemWerth Inc

    Find a price of Bromfenac Sodium bulk with DMF offered by ChemWerth Inc

    Find a price of Clevidipine bulk with DMF offered by ChemWerth Inc

    Find a price of Dexmedetomidine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Disodium Pamidronate Pentahydrate bulk with DMF offered by ChemWerth Inc

    Find a price of Eltrombopag bulk with DMF offered by ChemWerth Inc

    Find a price of Epinastine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Esmolol Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Etomidate bulk with DMF offered by ChemWerth Inc

    Find a price of Fosphenytoin Sodium bulk with DMF offered by ChemWerth Inc

    Find a price of Lapatinib Ditosylate bulk with DMF offered by ChemWerth Inc

    Find a price of Melphalan bulk with DMF offered by ChemWerth Inc

    Find a price of Melphalan Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Methylene Blue bulk with DMF offered by ChemWerth Inc

    Find a price of Milrinone bulk with DMF offered by ChemWerth Inc

    Find a price of Mitomycin bulk with DMF offered by ChemWerth Inc

    Find a price of Nelarabine bulk with DMF offered by ChemWerth Inc

    Find a price of Nepafenac bulk with DMF offered by ChemWerth Inc

    Find a price of Nicardipine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Pemetrexed Disodium bulk with DMF offered by ChemWerth Inc

    Find a price of Penciclovir bulk with DMF offered by ChemWerth Inc

    Find a price of Selenious Acid bulk with DMF offered by ChemWerth Inc

    Find a price of Sodium Nitroprusside bulk with DMF offered by ChemWerth Inc

    Find a price of Spinosyn D bulk with DMF offered by ChemWerth Inc

    Find a price of Tetrabenazine bulk with DMF offered by ChemWerth Inc

    Find a price of Tiagabine Hydrochloride bulk with DMF offered by ChemWerth Inc

    Find a price of Ziprasidone Mesylate bulk with DMF offered by ChemWerth Inc

    Find a price of Tobramycin bulk offered by ChemWerth Inc

    Find a price of Abaloparatide bulk offered by ChemWerth Inc

    Find a price of Amifostine Trihydrate bulk offered by ChemWerth Inc

    Find a price of Amphotericin B bulk offered by ChemWerth Inc

    Find a price of Nitenpyram bulk offered by ChemWerth Inc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search